MEDIZINISCHE ABGABEVORRICHTUNG

European patent · EP3389593 · In force

Register entry

Publication number
EP3389593
Application number
EP16822125
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 13, 2016
Published
Oct 24, 2018
Granted
Apr 24, 2024
Protection ends at the latest
Dec 12, 2036
Next annual fee due
Dec 31, 2026
IPC classes
A61J 1/20 (2006.01)
A61M 5/178 (2006.01)
A61M 5/315 (2006.01)
A61M 5/32 (2006.01)
A61M 5/20 (2006.01)
Priority
EP 15199911 14.12.2015
EP 15199909 14.12.2015
EP 15199913 14.12.2015
EP 15199915 14.12.2015
EP 16167999 03.05.2016
PCT application
PCT/EP2016/080823 13.12.2016
PCT publication
WO2017/102742 22.06.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Mar 5, 2025

    Change

    Published in Swissreg on 05.03.2025

  3. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  4. Jun 14, 2024

    Agent entered

    Representative
    Latscha Schöllhorn Partner AG, Grellingerstrasse 60, 4052 Basel

    Published in Swissreg on 14.06.2024

  5. Apr 24, 2024

    Granted

    Published in Swissreg on 24.04.2024

Parties

Holder

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Agent

Latscha Schöllhorn Partner AG

Grellingerstrasse 60, 4052 Basel

Inventor

GAILLOT, Maxime

4070 Basel

HAYTON, Paul, Graham

St Andrews Bristol BS6 5AU, GB

RIDLEY, Jonathan, Paul

Bristol BS3 4PE, GB

REILLY, Declan

4070 Basel

TEUCHER, Mark, Digby

Lansdown Bath BA1 5SW, GB

COOP, James, Robert

Clifton Bristol BS8 4ED, GB

LEAH, Roberta

4070 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.